Q3 2026 · CIK 1854794 Snapshot · — Export CSV
Manager file · PTNT · Patient Capital Management, LLC

Samantha McLemore - Patient Capital Management

EDGAR CIK 1854794 ↗ · Filed · typical filing lag 44.0 days

Export CSV
Reported portfolio value
$3.15B
QoQ reported +3.1% · vs Q2 2026
Positions
41
4 new · 3 exited
Top 10 concentration
50.4%
largest position 6.3%
Position churn · Q3 2026
5 added · 25 trimmed
new positions 6.6% · exits 0.0% of book
Holdings · Q3 2026 · 41
Security Weight Δ wt Price* Shares Δ shares Value Action
1 — ROYALTY PHARMA PLC 6.35% -0.3% $58 3.42M -4.9% $200M Trimmed
2 C CITIGROUP INC 5.72% -0.7% $129 1.39M -1.0% $180M Trimmed
3 GOOGL ALPHABET INC 5.67% -0.5% $344 518K -1.4% $178M Trimmed
4 AMZN AMAZON COM INC 5.36% +0.0% $249 677K -0.6% $169M Trimmed
5 NVDA NVIDIA CORPORATION 5.15% +0.5% $228 710K +0.0% $162M Held
6 UNH UNITEDHEALTH GROUP INC 4.97% -1.0% $367 426K -2.7% $156M Trimmed
7 PGEN PRECIGEN INC 4.88% +1.3% $9 17.95M -5.7% $154M Trimmed
8 META META PLATFORMS INC 4.17% +1.0% $725 181K +6.0% $131M Added
9 QXO QXO INC 4.06% +0.0% $12 10.93M +53.2% $128M Added
10 CHYM CHIME FINL INC 4.01% +1.3% $27 4.73M +15.9% $126M Added
11 — CALL META PLATFORMS INC 3.95% +4.0% $725 172K new $124M New
12 ET ENERGY TRANSFER L P 3.79% -0.0% $20 6.03M -0.8% $119M Trimmed
13 ADBE ADOBE INC 3.05% +0.6% $240 400K +10.9% $96.08M Added
14 FBTC FIDELITY WISE ORIGIN BITCOIN 2.82% +0.8% $73 1.22M +0.4% $88.83M Added
15 — NORWEGIAN CRUISE LINE HLDGS 2.78% -1.4% $15 5.97M -0.9% $87.56M Trimmed
16 COIN COINBASE GLOBAL INC 2.74% +0.5% $186 462K -0.1% $86.04M Held
17 CROX CROCS INC 2.73% -0.4% $117 731K -8.6% $85.75M Trimmed
18 — SEADRILL LTD 2.70% +0.3% $45 1.90M -2.6% $84.96M Trimmed
19 PPLI PEOPLE INC 2.67% -1.0% $42 2.00M -17.4% $84.11M Trimmed
20 AVGO BROADCOM INC 2.66% +2.7% $351 238K new $83.74M New
21 CVS CVS HEALTH CORP 2.64% -1.5% $86 970K -21.5% $83.12M Trimmed
22 UAL UNITED AIRLS HLDGS INC 2.53% -0.7% $111 717K -2.0% $79.50M Trimmed
23 GPN GLOBAL PMTS INC 2.43% +0.2% $82 937K -0.5% $76.55M Trimmed
24 BIIB BIOGEN INC 1.77% -0.2% $226 246K -13.1% $55.68M Trimmed
25 GM GENERAL MTRS CO 1.50% -0.1% $77 613K -3.0% $47.18M Trimmed
26 EXPE EXPEDIA GROUP INC 1.40% -0.0% $263 167K -0.4% $44.02M Trimmed
27 — CALL BIOGEN INC 1.36% +0.0% $226 189K +0.0% $42.78M Held
28 OMF ONEMAIN HLDGS INC 1.22% -0.2% $55 692K -1.5% $38.31M Trimmed
29 — UBS GROUP AG 1.08% -0.5% $48 704K -26.1% $33.91M Trimmed
30 FISV FISERV INC 0.97% -0.6% $45 674K -29.3% $30.46M Trimmed
31 SOFI SOFI TECHNOLOGIES INC 0.74% -0.1% $16 1.49M -1.3% $23.36M Trimmed
32 DAL DELTA AIR LINES INC 0.73% -0.6% $83 276K -36.0% $23.04M Trimmed
33 TEM TEMPUS AI INC 0.66% -0.1% $82 254K -36.6% $20.80M Trimmed
34 JPM JPMORGAN CHASE & CO 0.31% -0.0% $331 29K -0.0% $9.71M Held
35 — NOBLE CORP PLC 0.13% +0.0% $42 100K +0.0% $4.17M Held
36 JD JD.COM INC 0.12% -1.0% $27 139K -89.9% $3.70M Trimmed
37 APA APA CORPORATION 0.07% +0.0% $42 50K +0.0% $2.08M Held
38 — GENIUS SPORTS LIMITED 0.04% -0.1% $6 213K -73.8% $1.22M Trimmed
39 LEN/B LENNAR CORP 0.03% -0.0% $80 12K +0.0% $1,000K Held
40 — ISHARES TR 0.01% +0.0% $33 8,269 new $272K New
41 — SPDR SERIES TRUST 0.01% +0.0% $96 2,709 new $260K New
42 ILMN ILLUMINA INC 0.00% -2.0% — 0 345K → 0 $0 Exited
43 PLAY DAVE & BUSTERS ENTMT INC 0.00% -0.1% — 0 204K → 0 $0 Exited
44 SPY STATE STR SPDR S&P 500 ETF T 0.00% -0.0% — 0 1,060 → 0 $0 Exited

* Price = reported value ÷ shares at quarter end (13F does not disclose cost basis). Δ wt = this position's share of the reported portfolio versus the prior quarter. Options are shown separately when filed.

This quarter's moves
  • META PLATFORMS INC 3.95% · $124M
  • BROADCOM INC 2.66% · $83.74M
  • ISHARES TR 0.01% · $272K
  • SPDR SERIES TRUST 0.01% · $260K
  • ILLUMINA INC was 1.99% · 345K sh
  • DAVE & BUSTERS ENTMT INC was 0.08% · 204K sh
  • STATE STR SPDR S&P 500 ETF T was 0.03% · 1,060 sh
  • Filing detail
    Period2026-09-30
    Accepted12 Nov 2026 · 10:18 ET
    Filing lag43 days
    Form13F-HR
    Information rows41
    Quarters on file5
    Portfolio value
    Q1 2025Q2 2025Q3 2025Q2 2026Q3 2026$3.15B Q1 2025Q2 2025Q3 2025Q2 2026Q3 202641
    Quarterly history · 5 filings
    QuarterPeriod endReported valuePositionsLargestNewExitedFiledLag
    Q3 2026 2026-09-30 $3.15B 41 6.3% 4 3 12 Nov 2026 ET 43
    Q2 2026 2026-06-30 $3.05B 40 6.6% 6 7 13 Aug 2026 ET 44
    Q3 2025 2025-09-30 $2.50B 41 6.0% 2 1 29 Oct 2025 ET 30
    Q2 2025 2025-06-30 $2.22B 40 6.4% 4 3 13 Aug 2025 ET 44
    Q1 2025 2025-03-31 $1.94B 39 5.6% — — 14 May 2025 ET 44
    Track record · return since filing
    Paper return of each reported book
    Since Q1 2025
    +28.2%
    S&P 500 +28.4%
    Hit rate · latest book
    42%
    priced positions with positive return
    Priced coverage
    86%
    of reported stock value
    Q1 2025Q2 2025Q3 2025Q2 2026Q3 2026Reported bookS&P 500
    Quarter by quarter
    QuarterBookS&P 500ExcessCoverageBest call
    Q3 2026 -2.1% -2.0% -0.2% 86% CHYM +4.1%
    Q2 2026 -6.4% -4.3% -2.1% 85% CROX +21.6%
    Q3 2025 +5.5% +10.4% -4.8% 85% ILMN +102.2%
    Q2 2025 +8.8% +16.7% -7.9% 84% ILMN +98.0%
    Q1 2025 +28.2% +28.4% -0.3% 85% BIIB +111.6%
    Copy-trade simulation
    Hypothetical strategy
    +16.6%
    5 rebalances
    S&P 500 same window
    +28.4%
    excess -11.8%

    Simulation: at each filing date, buy the manager's ten largest reported common-stock positions in equal weight; hold until the next filing. Prices are split- and dividend-adjusted closes. It ignores the 45-day disclosure lag's cost to a real copycat beyond the filing-date entry, taxes, fees and liquidity. It is a reading aid, not a backtest of the manager's fund.